News

A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) about the COVID-19 Omicron variant.

Temporary telehealth services introduced as part of COVID-19 measures will become a permanent service in our health system.

The National NAIDOC Awards are an opportunity to recognise outstanding achievements by Aboriginal and Torres Strait Islander people at the community, national and international level.

2021 is quickly coming to an end. With the holidays just around the corner, a lot of us will be travelling interstate and visiting family and friends.

An update from Australia's Chief Medical Officer, Professor Paul Kelly, about the new Omicron variant of concern.

Today, we released the refreshed National Aboriginal and Torres Strait Islander Health Plan 2021-2031 in partnership between the Australian Government and Aboriginal and Torres Strait Islander health leaders.

On 1 June 2021, more than 90 stakeholders from all over Australia gathered in Queenstown, Tasmania to discuss service and learning consortia for allied health.

The Australian Government has launched the National Preventive Health Strategy 2021–2030, which will provide more balance to the health system by having a stronger focus on preventive health.

An update from Australia's Chief Medical Officer, Professor Paul Kelly, about the new Omicron variant of concern.

Spikevax (Moderna), also referred to as the Moderna COVID-19 vaccine, has been provisionally approved for use as a COVID-19 booster vaccine in people aged 18 years and older by the Therapeutic Goods Administration (TGA).

The COVID-19 vaccines used in Australia are critical in protecting against COVID-19 due to all variants, including the newly emerged Omicron variant.

The latest phase in our COVID-19 vaccination rollout program – to vaccinate children aged 5 to 11 years from 10 January 2022 – continues to be based on the best medical and scientific advice available.

Australia’s COVID-19 vaccination program will be extended to all children aged 5 to 11 from 10 January 2022 after the Australian Government accepted recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI).

An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 8 December 2021.

The Australian Technical Advisory Group on Immunisation (ATAGI) has made recommendations for the use of the Pfizer COVID-19 vaccine in children aged 5 to 11 years.

An update from Australia's Chief Medical Officer, Professor Paul Kelly, about the new Omicron variant of concern.

As international borders open, the Australian Technical Advisory Group on Immunisation (ATAGI) has issued updated advice for the rollout of influenza vaccines.

A statement from the Australian Health Protection Principal Committee (AHPPC) on managed quarantine arrangements for international travellers.

COVID-19 vaccination information kiosks are now open in shopping centres and events in Queensland and Western Australia to help you book a vaccination appointment.

The Australian Government has announced a $48 million investment into COVID-19 medical research as part of its ongoing COVID-19 pandemic response. Funding is from the Medical Research Future Fund (MRFF).

The Therapeutic Goods Administration (TGA) provisionally approved the Comirnaty Paediatric (Pfizer) COVID-19 vaccine for 5 to 11-year-olds on 5 December 2021.  

An update from Australia's Chief Medical Officer, Professor Paul Kelly, about the new Omicron variant of concern

An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 1 December 2021.

The Australian Technical Advisory Group on Immunisation (ATAGI) has noted the emergence of a new SARS-CoV-2 variant of concern, which has been named the Omicron variant.

Aboriginal and Torres Strait Islander HIV Awareness Week (ATSIHAW) is held each year in the first week of December. Now in its 8th year, ATSIHAW has been making sure that all Aboriginal and Torres Strait Islander people know about the risks of HIV.